Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Strategic objectives are a foundational component of a medical strategy and are informed by the product and therapeutic landscape – they bridge the gap between where you are now and where you want to be. The objectives ultimately lead to individual tactics and activities that will deliver on the strategy so it is imperative that the objectives are focused, specific and give proper guidance to the medical team and organization. Understanding how to develop robust strategic objectives is a skill that all Medical Affairs teams should possess. This webinar will help you build a foundational knowledge in medical strategy and objective development by covering key topics such as:
1) Consideration of the product and therapeutic landscape
2) Components of robust objectives
3) Importance of collaborative objective development
4) Fundamentals of measuring objectives
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
In today’s rapidly evolving pharmaceutical environment, Medical Affairs teams are under increasing pressure to understand how to go beyond “activity engagement” metrics and identify areas of opportunity to advance evidenced-based medicine and treatment with current available data.
This webinar will provide a historical perspective on value, as well as insights to help Medical Affairs professionals measure and demonstrate the impact of their activities in a complex environment.
As Medical Affairs teams strive to identify areas of opportunity and demonstrate their value, understanding the importance of data-driven strategies is essential. In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity.
Medical Affairs plays a critical strategic role in product launches, through scientific knowledge, clinical expertise and cross-functional collaboration. Comprehensive research of international product launches, with an objective set of criteria, has shown that less than 10% of recent launches were excellent. This research has also revealed that two key dimensions, unmet need and product differentiation, have the highest influence on launch success, and enabled the definition of four clear launch archetypes. The launch archetypes help to identify critical success factors (CSFs) to develop the most effective launch strategy, and facilitate launch planning. The CSFs also highlight the key areas where Medical Affairs can make the highest strategic impact to support product success and improve patient outcomes.
Through review of launch archetypes, product launch case studies and MAPS launch excellence guidelines, this webinar will examine, based on the prevailing pre-launch situation, the strategic focus areas for Medical Affairs teams to consider during launch preparation and discuss approaches to achieve excellence across key activities.
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
With the vast amount of data available today, Medical Affairs organizations are tasked with continuously enhancing their ability to gather, analyze and derive insights from various data sources. Information is compounding at an increasingly faster pace and, if harnessed effectively, can allow Medical Affairs executives to make insight-driven decisions that drive company-wide strategy. This presentation will focus on:
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
The volume of published Medical Information is doubling every 70-75 days and Medical Affairs teams tasked with disseminating and generating new evidence are facing more channels and sources of competition to reach and educate health care providers than ever before. This expert panel discussion will showcase innovative applications of internal performance management platforms such as the Medical Productivity Index (MPI) and external events, namely the 2022 Medical Affairs Innovation Olympics in pharma that illustrate examples of more continuous, real time feedback on performance, new data science analytics driven analysis of performance, more even distribution of accountability, and increased resources to accelerate learning and development. In addition, the webinar will explore both pharma and diagnostics strategies to explain how innovative performance management approaches translate into improved healthcare access and outcomes by analyzing patient and provider level data across internal functions and external institutions.
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
The transformation is happening now. Discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization. Using the MAPS Medical Affairs Vision 2030 as our roadmap, experts will discuss the criticality of:
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.